Pursuant to Regulation 39(3) and other applicable regulations of SEBI Listing Regulations, Ajanta Pharma has informed that Registrar and Transfer Agent of Company, Link Intime India has received intimation for loss of share certificate and request for issuance of duplicate share certificate from the shareholder, Manoj Kumar Sharma (Folio No: 0003663). As required under the SEBI Circular No. SEBI /HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th May, 2022, Registrar and Transfer Agent will issue ‘Letter of Confirmation’ in lieu of physical duplicate share certificate, after necessary due diligence. Details of the shareholder and share certificate are enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: